أعرض في EDS

Supplementary Data from Phase I Trial of a Novel Anti-HER2 Antibody–Drug Conjugate, ARX788, for the Treatment of HER2-Positive Metastatic Breast Cancer

التفاصيل البيبلوغرافية
العنوان: Supplementary Data from Phase I Trial of a Novel Anti-HER2 Antibody–Drug Conjugate, ARX788, for the Treatment of HER2-Positive Metastatic Breast Cancer
المؤلفون: Xichun Hu, Joyce O'Shaughnessy, Yajia Gu, Qin Xiao, Weina Shen, Dongmei Ji, Jian Zhang
بيانات النشر: American Association for Cancer Research (AACR), 2023.
سنة النشر: 2023
الوصف: Supplementary Data from Phase I Trial of a Novel Anti-HER2 Antibody–Drug Conjugate, ARX788, for the Treatment of HER2-Positive Metastatic Breast Cancer
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cccb63d23d4c2bbc73bea3e634edd851
https://doi.org/10.1158/1078-0432.22489131
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....cccb63d23d4c2bbc73bea3e634edd851
قاعدة البيانات: OpenAIRE
الوصف
الوصف غير متاح.